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ABSTRACT 
Objective: Here the objective of this study was to prepare and characterize sustained release metformin loaded microsphere formulation which 
was prepared by W1/O/W2 emulsion solvent evaporation technique.  
Methods: Guar gum and sodium alginate were used as a matrix building material, whereas ethyl cellulose was applied as a coating polymer. Here 
various formulations were prepared by changing the drug and guar gum ratio, and the subsequent drug entrapment efficiency (DEE) and drug 
release were compared and evaluated.  
Results: Scanning Electron Microscopy (SEM) studies revealed spherical particles with a smooth appearance. Fourier-transform infrared 
spectroscopy (FTIR) showed there was no interaction between the ingredients in the final formulation. X-ray Diffraction (XRD) studies showed the 
emergence of polymorphic forms in the final formulation. The drug entrapment in the final drug loaded microsphere formulations was varied from 
30-66.78%. The drug release studies showed the continuous release of the drug through twelve hours. The optimized formulation (f2) found to 
release 71.5% of drugs at the end of the 12th hour following zero order release kinetics.  
Conclusion: The increase in gum concentration in the W1 phase, which enhances viscosity in the W1 phase, resulting in an increase in the drug 
entrapment up to an optimum level and a decrease in the release rate. So, it can prolong the action. So by using this tool, we can say that metformin 
loaded microsphere formulation would be a suitable pharmaceutical formulation for the treatment of diabetic patients in modern drug therapy for 
its prolonged action.  
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Diabetes mellitus is a complex phenomenon resulting in a big 
number of setbacks throughout the world. It is estimated as one of 
the five major causes of death globally. Almost 150 million people 
are affected by Diabetes internationally [1]. 
Metformin, a white crystalline, hygroscopic powder of a 1, 1-
dimethyl biguanide analog used as an antidiabetic drug from times 
immemorial. It has a scientific name N-N-dimethyl imido di-carbon 
amide diamide hydrochloride (fig. 1) [2]. 
 
 
Fig. 1: Chemical structure of metformin hydrochloride 
 
It reduces blood sugar by mainly blocking neoglucogenesis rather than 
increasing the secretion of insulin from the islets of Langerhans in the 
pancreas [3]. According to some experts, metformin is a drug of choice 
for newly diagnosed type-2 diabetes and perhaps the best oral 
hypoglycemic agent proven to decrease cardiovascular mortality [4]. It 
is also used in polycystic ovary syndrome as it can reduce insulin 
resistance so as to produce ovulation and pregnancy [5]. The drug 
generally works by suppressing hepatic neoglucogenesis and 
decreasing glucose output in the liver. It also increases insulin-
mediated glucose disposal in muscle and fat. It increases the GLUT 1 
transport from intracellular site to the plasma membrane. It also 
decreases the rate of intestinal absorption of glucose, other hexoses, 
amino acids, and Vit-B12. It increases peripheral glucose utilization by 
enhancing anaerobic glycolysis [6]. In diabetic patients, the blood 
sugar level should be maintained at a certain level for a long period. So, 
a sustained or controlled release dosage formulation will be beneficial 
for proper controlling of diabetes mellitus. 
Microsphere formulations provide longer duration of drug action 
with minimal gastric irritation. As microsphere preparations contain 
the drug embedded in the matrix made of guar gum and sodium 
alginate, resulting in a continuous slow release through a longer 
period [7]. Metformin decreases blood glucose levels in the patients, 
those who do not produce insulin in appreciable quantity to control 
hyperglycemia [8]. So, the microspheres of metformin will be very 
helpful to fight against hyperglycemia for a longer duration [9]. 
Guar gum is used in food and pharmaceutical industries for longer 
times [10]. It is a natural nonionic polysaccharide obtained from the 
seeds of Cyamompsistetra tetragonolobus (Family-Leguminosae). It 
is hydrophilic in nature and produces its swelling property in cold 
water. Its gelling property is useful in producing a delay in the drug 
release so a better choice for controlled release formulations [11]. 
In this study, microsphere of metformin was prepared with an 
optimum concentration of all ingredients and guar gum was used as 
a matrix building material in combination with sodium alginate to 
provide a controlled and prolonged release for a longer time. 
MATERIALS AND METHODS 
Materials 
Metformin was gifted from Stadmed Pharmaceuticals, Kolkata, India. 
Ethyl cellulose was purchased from Quest chemicals Kolkata, India. 
Dichloromethane, tween-80 and span 80 were purchased from 
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Merck India. All other reagents were of analytical grade. Guar gum 
was collected from Bikaner district of Rajasthan, India. 
Animals  
A Sub-acute (14 d) toxicity study on Wistar rats was conducted 
according to the OECD 407 guideline (OECD, 2008). The 
maintenance of animal handling and care were performed under the 
guidelines of the Committee for the Purpose of Control and 
Supervision of Experiments on Animal (CPCSEA). Male Wistar rats 
(weight: 120-130 g) were selected for the toxicological evaluation of 
animals of both sexes were designated within the same weight 
range. Precautions were taken to ensure that the selected female 
animals were nulliparous and non-pregnant. The animals will be 
acclimatized under the standard controlled conditions, 
(temperature, 25±5 C; relative humidity, 55±10%) with light and 
dark cycle of 14 h and 10 h, respectively. A period of 7-10 d was 
provided to the animals to acclimatize under stipulated laboratory 
conditions prior to the initiation of experimentation. Throughout the 
experimental period, animals were housed in polypropylene cages 
provided by the standard pellet diet (Hindustan Lever Ltd., Mumbai, 
India) and water ad libitum [12]. 
Methods 
Preformulation studies 
Preparation of stock solution 
The stock solution was prepared by dissolving 10 mg of the drug in 
50 ml of distilled water kept in a 100 ml of volumetric flask. Then the 
solution was made to 100 ml by adding distilled water, and 100 
µg/ml stock solution was prepared. 
Determination of λmax 
10 µg/ml of drug solution was prepared from the stock solution. The 
absorbance in the UV spectrum was determined by scanning of a 
range 200 nm to 400 nm, and maximum absorbance was found at 
233 nm while distilled water was used as a blank. So the λmax of the 
sample was 233 nm. 
Preparation of standard curve 
Seven point calibration curve was prepared by spiking appropriate 
amounts of the stock solution into the corresponding buffer to obtain a 
final concentration of 5,10,15,20,25,30, 35 μg/ml for the analysis. 
Absorbance was studied at 233 nm, and a calibration curve was 
prepared by plotting absorbance against the concentration (fig. 2). 
 
 
Fig. 2: Seven point calibration curve of metformin at 233 nm 
wavelength of pH 6.8 and 1.2 
 
Swelling index 
1 gm of Guar gum was added in pH 6.8 buffer solution, 10 ml of 
distilled water and 0.1 N HCl solution. Then it was shaken for 10 min 
in a magnetic stirrer at high speed and allowed to stand for 24 h. 





Microbial load study 
The pour plate method was applied to study the microbial and 
fungal load of the sample. Two sterilized Petri dishes were taken, 
and Soybean-Casein digests agar medium was poured into both the 
Petri dishes aseptically with fresh guar gum and ten months older 
sample respectively. After solidification of the media, both the Petri 
dishes were placed in the incubator at 37˚C for one day. A total 
number of colonies were counted by the Coulter Counter method. In 
the same way, the total number of the fungal count was done by 
using potato dextrose agar medium [14]. 
Toxicity study 
The subacute toxicity study was conducted on male Wistar rats 
(120-130 g). The solution of guar gum at a dose of 100, 200 and 400 
mg/kg body weight was administered orally to the three groups of 
six rats, respectively, for every day 14 d and control received a 
vehicle of the same volume. The toxic manifestation, i.e. body weight, 
mortality, and behavioral changes were regularly monitored. After 
14 d all the surviving animals were fastened overnight and 
anesthetized with diethyl ether, and the heparinized blood samples 
were collected for determination of hematologic parameters and 
animals were sacrificed by euthanasia for the collection of internal 
organs kidney and liver. Then the collected organs were preserved 
in 10% formaldehyde solution for histopathological examinations. 
The research was conducted in accordance with the ethical rules on 
animal experimentation approved by the Ethical Committee, 
Department of Pharmaceutical Technology, Jadavpur University 
(Approval No: 147/1999/CPCSEA). 
Preparation of microsphere 
A small amount of sodium alginate was dissolved in 5 ml of distilled 
water in a small beaker placed on a magnet stirrer. Guar gum was 
added to it with continuous stirring. Metformin as a weight of 80 mg 
was added to it and stirring was done for almost half an hour by a 
magnetic stirrer. Then the preparation was taken with a 20 gauge 
needle. An organic solution was prepared with 1 gm of ethyl 
cellulose and 30 ml of dichloromethane (DCM). Then 300 µl of span 
80 was added to this organic solution. This preparation was 
transferred to the Homogenizer tube. The Homogenizer tube was 
subjected to rotation at approx 4500 RPM while the drug solution 
was poured drop by drop into it from the 20 gauge needle. A 
primary emulsion of W/O type was produced. A water phase was 
prepared with 100 ml of distilled water and 200 µl of tween 80. The 
preparation was kept under a mechanical stirrer rotating at 780-800 
RPM. The primary emulsion was then poured into the water phase 
drop wise by a 16 gauge needle and rotated for 3.5 h through 
mechanical paddle stirrer. Small spherical microspheres were 
formed which were filtered, air dried, weight and stored in a 
desiccator for future study [15]. 
Characterization of prepared microspheres 
Percentage Yield 
The percentage yield of Microsphere was calculated using the ratio 
of practical yield and theoretical yield. Practical yield is the weight of 
the microsphere obtained. Theoretical yield is the total weight of the 
raw materials [16]. 
Percentage	of	yield	  	 Practical	yield/Theoretical  100 
Drug entrapment efficiency 
A small amount (40 mg) of prepared microspheres were triturated 
properly and made into powder form, and then 100 ml of phosphate 
buffer (pH 6.8) was added to it. This preparation was subjected to 
magnetic stirrer for 2 h. Filtration of the solution was done by Whatman 
filter paper. 10 ml of this stock solution was diluted with phosphate 
buffer (pH-6.8) and analyzed for metformin content at 233 nm [17]. 
Drug	entrapment	efficiency	DEE
 Experimental	drug	content
/Theoretical	drug	content	  100 
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Particle size distribution and zeta potential 
The particle size distribution was obtained from the optical 
microscopic method. The mean average diameters of the 
microsphere particles were obtained in the SEM studies.  
A weighed quantity of the experimental sample was dispersed in 
Milli-Q water (Milli-Q, Merck Millipore, Billerica, MA, USA) by 
vortexing and then sonicated and placed in a cuvette for zeta 
potential measurement [18]. 
Scanning electron microscopy (SEM) analysis 
Particle size, shape and surface morphology were detected by SEM 
analysis. SEM was done by CARL ZEISS EVO 18 special edition 
machine with the platinum coating. The platinum coating was done 
by QUORUM Q150 TES machine [19]. 
Fourier transform infrared spectroscopy (FTIR) study 
Fourier transform infrared spectroscopy (FTIR) was done to find out 
if there were any chemical interactions between the drug molecule 
and other ingredients used in the microsphere preparation. It was 
done on IR-Prestige-21, Shimadzu, Japan [20]. 
X-ray diffraction (XRD) studies 
The samples of various batches were evaluated by X-ray diffraction 
studies. XRD studies were done by X-ray diffractometer of model no 
Ultima-111, Renuka (Japan), Cu target slide 10 mm. The possible 
drug-polymer interaction was detected by XRD studies of the drug 
and the drug-loaded microsphere [21]. 
Drug release study 
A drug release study was done in the dissolution test apparatus, LAB 
INDIA DS 8000 USP–type 2 (paddle type) apparatus calibrated at 37˚C 
and rotated at 50 RPM. In the dissolution test apparatus initially, 750 ml 
of acid buffer of pH-1.2 was added, and microspheres of 50 mg were 
added into it. Then after 2 h, 150 ml of trisodium orthophosphate buffer 
solution was added into the acidic solution so that the resultant pH of the 
solution became 6.8. From the final solution, 5 ml of the sample was 
withdrawn in every 1 hour, and it was replaced by 5 ml of phosphate 
buffer of pH 6.8 every hour. The same thing was done at initial 2 h 
maintaining pH 1.2. This process was continued for 12 h [22]. 
RESULTS 
Swelling characteristics of the gum 
Swelling capacity of guar gum in distilled water, 0.1NHCl and pH 6.8 
buffers were described fig. 3. Here the swelling index of the gum was 
slightly higher in 0.1 N HCl than in buffer 6.8 and distilled water. 
 
 
Fig. 3: Represents the swelling characteristic of guar gum at 
different pH (1.2 and 6.8). SD; Standard deviation of n=3 
 
Microbial load 
According to I. P. (4th edition, 1996), the microbial and fungal load 
should be less than 1000 CFU/g and 100 CFU/g. The Microbial count 
was found to 290 CFU/g and 265 CFU/g for the older and the fresh 
sample of guar gum. The fungal count was found to be 75 CFU/g 
and73 CFU/g for the older and the newer sample of gum. 
Toxicity study of guar gum 
Treatment with guar gum at doses of 100, 200 and 400 mg/kg b. 
w maintained the hemoglobin counts towards the normal levels. 
The RBC count was also maintained to a normal range on 
treatment with guar gum (100, 200 and 400 mg/kg b. w). Guar 
gum at an optimal dose of 200 and 400 mg/kg b. w slightly 
brought down the WBC level. In the differential count, 
lymphocytes and monocytes were found to have minimal 
changes, and the neutrophils levels were little decreased in the 
drug-treated group when compared with the healthy group. Guar 
gum treatment at different doses as above significantly changed 
the relevant parameters approximately, to the normal values. 
Table 1 demonstrated the biochemical parameters SGOT, SGPT, 
SALP, and bilirubin not significantly changed (100, 200 and 400 
mg/kg B.w.) as compared to a healthy control group. Results 
show platelets content also lightly increased dose-dependently 
in comparison to the normal. 
Also in the histopathological studies (fig. 4) HandE stained sections 
of liver slices of healthy rat, shown in fig. 4, exhibiting the presence 
of all the normal features, including circular hepatic portal vein and 
a branch of the hepatic artery, as marked by arrows. The 
hepatocytes show prominent nuclei (fig. 4, marked by arrow) and 
the tissue section comprised hepatic sinusoids as usual. On the other 
hand, fig. 4, none of the regular features as above mentioned could 
be found, rather it revealed extensive hepatocellular lesions, as 
pyknotic nuclei, exhibiting necrotic hepatocytes in guar gum treated 
groups. On treatment using test compound, the cellular features 
were found (fig. 4), some irregularities, e. g., deformity in the hepatic 
artery and irregular bile duct could be found. Along with this, guar 
gum treatment at a dosage of 100, 200 and 400 mg/kg b. w, very 
least amount of phenotypic alteration and altered hepatocyte 
population were found (fig. 4), marked by the presence of healthy 
hepatocytes although a mild dilation of the central vein could be 
observed. On escalation of the dose to 200 and 400 mg/kg b. w, (fig. 
4) the cellular and overall features were close to normal as had 
shown in marked by the presence of healthy hepatocytes, regular 
central vein, branch of the bile duct and hepatic artery exhibiting the 
superiority of the same. Histopathological evaluation of the normal 
kidney tissue of the rats demonstrated the normal structure of 
glomerulus surrounded by the Bowman’s capsule, distal convoluted 
tubules and proximal convoluted tubules without any inflammatory 
alterations (fig. 4). The groups that were treated with guar gum at 
doses of 100, 200 and 400 mg/kg b.w. demonstrated normal 
glomerulus, normal basement membrane, capillaries collecting 
ducts, tubules, ascending and descending loops without any 
inflammatory cells as compared to the normal healthy rat (fig. 4 
marked by arrow).  
Percentage of yield and encapsulation efficiency 
The percentage yield and encapsulation efficiency of metformin 
were varied in all microsphere formulations. The percentage 
yield of microspheres varied from 42.20±0.83 % to 
94.84±1.88%. It was also found that with the increase in the 
amount of guar gum in the internal phase the percentage yield 
was also increased. Due to the variation of drug and guar gum 
ratio, formulations were affected in table 2. The loading was 
increased upto an optimum ratio of drug and guar gum after 
which an increase in the ratio this decreases the drug loading. 
Average particle size determination and zeta potential 
The particle size of the microspheres found to be increasing after a 
certain size range of 327.08 µm. After this optimum concentration 
(table 3), the particle size became larger with the increase in the 
amount of the guar gum. With the increase in the amount of guar 
gum in the solution resulted in an increase in the viscosity of the 
solution which provoked bigger particle formation. So after an 
optimum concentration of guar gum with the increase in the 
concentration of the guar gum particle size was also increased. 
Chatterjee et al. 
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Table 1: Effect of guar gum on blood hematological and biochemical parameter 
Parameters Control Guar gum (100 mg/kg) Guar gum (200 mg/kg) Guar gum (400 mg/kg) 
Hemoglobin (gm%)  14.41±0.023  14.40±0.034 ** 14.45±0.026 ** 14.38±0.011 ** 
RBC (106/µl)  8.64±0.037  8.62±0.089 ** 8.71±0.201 ** 8.85±0.056 ** 
WBC(103/μl)  13.73±0.068  13.65±0.048** 13.55±0.075 ** 14.02±0.022 ** 
Neutrophil (103/μl)  21.77±0.658  22.01±0.358 ** 21.92±0.661 ** 22.56±0.454** 
Monocyte (103/μl)  2.33±0.347 2.31±0.060 ** 2.55±0.214** 2.73±0.124 ** 
Lymphocyte(103/μl)  73.56±0.347  73.67±0.627 ** 73.78±0.653 ** 72.89±0.583** 
Eosinophil(103/μl)  2.35±0.177 2.32±0.748** 2.57±0.432 ** 2.21±0.654 ** 
Platelets (103/μl)  1231.01±1.066  1238.00±1.811** 1241.00±0.713 ** 1241.01±1.036 ** 
SGOT (U/l)  88.99±0.323  89.11±0.437 ** 89.42±0.552** 89.23±0.331** 
SGPT (U/l)  32.63±0.541  32.32±0.643 ** 31.19±0.430 ** 33.14±0.473 ** 
The each point represents the mean±SEM. (n= 6 mice per group). **p<0.01 statistically significant when compared with the normal saline group and 
drug-treated group.  
 
 
Fig. 4: Histopathological studies, HandE stained sections of liver and kidney slices of healthy rats. Liver slices are exhibiting the presence 
of all the normal features, including circular hepatic portal vein and branch of the hepatic artery, as marked by arrows. Kidney slices 
demonstrated normal glomerulus, normal basement membrane, capillaries collecting ducts, tubules, ascending and descending loops 
without any inflammatory cells as compared to the normal healthy rat (marked by the box). SD; Standard derivation for n=6 
 
Table 2: Percentage of yield as well as drug entrapment efficiency of different formulations along with the different drug-gum ratio 
Formulation code Drug: guar gum % of yield % of DEE 
F1 1:0.22 42.20±0.83 30±1.45 
F2 1:0.37 49.16±1.27 53.1±1.52 
F3 1:0.50 49.58±0.63 59.5±1.07 
F4 1:0.62 49.65±0.56 66.78±2.1 
F5 1:0.75 52.14±0.28 50.15±2.23 
F6 1:0.87 89.38±1.32 32.5±1.89 
F7 1:1 94.84±1.88 35.75±1.47 
SD; Standard deviation for n= 3 
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Table 3: The average particle size of drug-loaded microspheres with a different drug-gum ratio 
Formulation code Drug: guar gum Average particle size (µm) Zeta potential(-mV) 
F1 1:0.22 327.08±2.45 11.13±0.11 
F2 1:0.37 392.08±1.96 13.21±0.92 
F3 1:0.50 397.78±3.61 10.35±0.12 
F4 1:0.62 540.42±2.55 9.98±0.23 
F5 1:0.75 548.77±1.39 9.32±0.45 
F6 1:0.87 553.48±5.38 8.91±1.07 
F7 1:1 556.48±4.15 8.21±0.15 
SD; Standard deviation for n= 3 
 
Scanning electron microscopy (SEM) study 
The SEM was used to determine the particle size distribution, 
surface morphology, texture and also to examine the morphology 
of the fracture or sectioned surface of the prepared 
microspheres. The absence of pores in the microspheres was of 
major importance for the underlying drug release mechanisms 
because drug releases through the water-filled cavities were 
much faster than through dense polymeric matrix network. All 
microspheres were spherical in shape; smooth surfaced and had 
minuted pores on the surface. In (fig. 5) SEM studies indicated 
the spherical surface of the microsphere. The surfaces of the wall 
of the microspheres were rough and showing small holes due to 
the evaporation of the solvent. The surface of drug-loaded 
microspheres was found to be smooth with small pores whereas 
the surface of blank microspheres was rough having larger 
pores. In the study, the microsphere formulations with guar gum 
having smooth surface showed a slow and prolonged drug 
release profile as compared to the microspheres formulation 
without guar gum. 
 
 
Fig. 5: A-Drug-loaded microspheres showing an apparently smooth surface, the existence of minute holes in the surface due to the rapid 
evaporation of the solvent in the magnetic stirrer. B-The best-optimized formulation (f2) showing smooth texture on the outer surface 
with a fine round shape in the appearance. Little roughness in the external surface helped its fine attachment with the intestinal lumen. C-
The blank microsphere without the drug, having a spherical shape and rough in appearance. D-As, the concentration of the gum, 
increased in the internal phase so it produced a larger size due to the increase in viscosity in the W1 phase of W1/O/W2 microemulsion 
 
 
Fig. 6: 1. Blank-No peak was found at 3172 cm-1 due to N-H stretching, At 1065 cm-1 no peak was found due to C-N stretching, At 1590 cm-
1 no peak was found due to N-H bonding of the primary amine group. 2. Drug-At 3172 cm-1 sharp peak due to N-H stretching, At 1065 cm-
1 peak was found due to C-N stretching, At 1590 cm-1 a peak was found due to N-H bonding. 3. The formulation-almost similar peak at 
3172 cm-1 due to N-H stretching, (Microsphere) At 1065 cm-1 a peak was found for C-N stretching, At 1590 cm-1 a little bit similar peak 
was found due to N-H bonding 
Chatterjee et al. 
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Fourier transform infrared spectroscopy (FTIR) study 
FTIR was conducted to study the chemical interactions between the 
active ingredient metformin and all the other excipients used in the 
microsphere formulations. The entire observed spectrum is 
represented in fig. 6 where the characteristic peaks of drug-loaded 
microspheres were compared with that of the standard spectrum of 
metformin. From the FTIR studies, it was found that no chemical 
interaction occurred between the drug metformin and guar gum and 
polymer ethyl cellulose. The absorption peak of the drug found at 
3172 cm-1 due to N-H stretching of the primary amine group (-
NH2). At 1065 cm-1 due to C-N stretching a peak of metformin was 
found. At 1590 cm-1 at peak due to N-H bending of the primary 
amine group. The same type of peaks appeared (N-H stretching, C-N 
stretching and N-H bending vibrations) in the spectra of guar gum 
containing microspheres of metformin. Although, similar 
characteristic peaks were not found in the blank microsphere 
formulations. 
XRD study  
According to the powder crystalline theory, the crystalline 
substances found to contain a well-defined structure. Atoms, ions, 
and molecules were arranged in a three-dimensional lattice which 
resulted in a tighter packing of components so well defined edges 
and faces diffract X-ray in a regular pattern. Amorphous solids had 
curved, and the irregular surface so did not provide well-resolved 
diffractogram. The powdered x-ray diffraction of metformin, drug-
loaded microsphere and guar gum were shown in the fig. 7. The 
diffraction pattern of pure metformin and metformin loaded 
microsphere showed a crystalline peak, but guar gum alone gave an 
amorphous peak. The result demonstrated that the crystalline peak 
of metformin and metformin loaded microsphere formulations were 
almost similar, but peak intensity diminishes in the formulation 
diffractogram due to dilution of the drug with gum and polymer. So, 
it can be said that the conducted XRD experiment also suggested that 
metformin was compatible with gum and other excipients. 
 
 
Fig. 7: A-Pure metformin introducing sharp crystalline peaks as there was no existence of polymorphic form. B-Metformin microsphere 
formulation containing both the drug and the excipients. Due to the presence of the drug crystalline peaks were found, whereas gums and 
excipients were responsible for the existence of polymorphic forms in the chromatogram. C-XRD study of gum showing the amorphous 
type of picture containing no crystalline peaks 
 
Dissolution study 
The mechanism of drug release from the microsphere formulations 
was biphasic in nature. Dissolution was carried out, and it was 
observed that the drug release from the microspheres in an acidic 
solution (pH-1.2) was slow in comparison to an alkaline solution 
(pH-6.8) (fig. 8). The collected drug release data from the dissolution 
test was evaluated using a number of kinetic models. 
 
 
Fig. 8: Dissolution profile of F1 to F batches are depicted here in the figure. F1 batch is having the lowest concentration of gum showing 
the highest percentage of drug released (85%). The optimized formulation F2 is showing 72% of drug released in 12 h. With the 
concentration of the gum release of the drug from the microsphere was retarded. SD; Standard derivation for n=3 
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The best-fitted model was analyzed by comparing the correlation 
coefficient values of different mathematical models in table 4. From 
the recorded data the correlation coefficient value of drug loaded 
microsphere formulation (r2=0.99) was found to be higher and 
suitable according to the percentage of yield, the percentage of DEE 
and particle size than the other drug loaded microsphere 
formulations. The Zero Order kinetic model was the best satisfactory 
mathematical model for the microsphere formulation (f2).  
 
Table 4: Drug release profile in dissolution media from different drug loaded microsphere formulations 
Formulation code Zero-order First order Higuchi Korsmeyer-peppas Hixon crowell 
K0 R20 K1 R21 Kh R2h n Kkp R2kp Khc R2hc 
F1 6.983 0.9833 -0.064 0.8986 29.39 0.9175 0.8929 0.9008 0.9419 0.211 0.9949 
F2 5.90 0.9905 -0.045 0.957 26.87 0.9607 0.941 0.8245 0.9767 1.4521 0.9579 
F3 5.423 0.8888 -0.0369 0.8161 20.65 0.7687 0.9646 0.5794 0.8503 0.206 0.9557 
F4 3.6936 0.9411 -3.6936 0.9411 16.24 0.8537 0.926 0.5307 0.871 0.1745 0.9804 
F5 3.547 0.9885 -0.02 0.9009 16.00 0.9436 1.1988 0.3045 0.9757 0.1873 0.9618 
F6 3.924 0.9879 -3.924 0.9879 17.77 0.951 1.18 0.3742 0.9619 0.214 0.9765 
F7 2.837 0.9831 -0.0161 0.9917 13.117 0.9855 0.7119 0.8061 0.9702 0.1274 0.9384 
From the table, it is found that all the formulations released the drugs up to twelve hours. The best formulation F2 following zero-order drug release 
kinetics with almost 72% release of the drug 
 
 
Fig. 9 Graphical abstract of metformin loaded microsphere 
 
DISCUSSION 
Guar gum and sodium alginate were used as matrix building 
materials whereas ethyl cellulose was applied as a coating polymer 
and these produced metformin loaded microsphere by W1/O/W2 
emulsion solvent evaporation technique. Initial experiments showed 
that a higher volume of the organic phase and internal aqueous 
phase as well as processing temperature considerably reduced DEE 
of the microsphere. If the volume of organic solvent increases, then 
the time required for evaporation of this solvent will be more which 
provides greater opportunity for the drug to partition from W1 to W2 
phase. As a result, DEE of the microsphere decreased (66.78 to 
35.75). A previous report represented that the entrapment efficiency 
of vitamin B12 in poly (Є-caprolactone) microparticles decreased 
when the volume of external aqueous phase was increased and vice-
versa [23].  
At the time of preparation of microsphere by W1/O/W2 emulsion-
solvent evaporation method, the organic phase separated the internal 
and external aqueous phases and acted as a diffusion barrier for the 
drug between the two aqueous phases. Higher the internal aqueous 
volume may increase the volume of W1 droplets in the oil phase and 
consequently may decrease the thickness of the organic polymer 
phase. This promoted more partitioning/leaching of the drug from 
internal to external aqueous phase. As a result, the DEE of the 
microcapsules decreased. The observation is in agreement with the 
results of other researchers [24-25]. In this research DEE also varied 
due to changes in the ratio of guar gum and these changes gave 
maximum DEE (66.78 %) at a particular ration (drug: guar gum= 
1:0.62) and decreased DEE followed by an increase in gum ratio. And 
also the percentage of yield of microsphere was proportionate with 
the gum ratio (94.4 at 1:1 drug: guar gum). 
Increasing the volume of the internal aqueous phase (W1) tended to 
increase the size of the microsphere [26]. Increase in volume of W1 
phase increased the number of dispersed droplets in a fixed volume of 
the organic phase, and the probability of coalescence between the 
dispersed droplets increased. This resulted in an increase in the size of 
the microsphere. Similar results had reported by various workers [27]. 
Incorporation of guar gum concentration in the W1 phase also 
affected the size of the matrix microsphere (327.08 µm to 556.48 
µm). An increase in the concentration of guar gum increased the size 
of the microsphere (table 5). As the concentration of guar gum was 
increased, the viscosity of the W1 phase also increased. This 
hindered easy breakdown of W1 phase into smaller droplets. In 
addition, an increase in viscosity of W1 phase made the primary 
W1/O emulsion more viscous and formed larger W1/O/W2 emulsion 
droplets. As a result, the bigger size of microspheres were formed 
(556.48 µm). 
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Table 5: Parameter of the release of drug from the metformin loaded microsphere 
Formulation code t50% (h) t80% (h) 
F1 7.53 11.85 
F2 8.38 12.23 
F3 10.82 ----b 
F4 ----a ----b 
F5 ----a ----b 
F6 ----a ----b 
F7 ----a ----b 
---a Drug release was less than 50% in 12 h.---b Drug release was less than 80% in 12 h 
 
The release of drug from the microsphere which was prepared with the 
different concentration of gum of the inner aqueous phase was slow. 
Replacement of the dissolution medium after 2 h with phosphate buffer 
(pH 6.8) produced a sudden increase in the release, which extended for 
different periods of time depending on the concentration of the gum in 
the W1 phase. Such a difference in release in the two dissolution media 
may be attributed to the pH-dependent solubility of the drug which was 
poorly soluble in acidic solution and more soluble in an aqueous solution 
of higher pH. In addition, as the concentration of the gum in the W1 
phase was increased, the release of the drug in both the dissolution 
media decreased. The time required for 50% (t50%) and 80% (t80%) 
drug release was determined from the cumulative percentage release 
versus time curves. Here t50% was found to increase from 7.53 h to 
10.82 h, and t80% increased from 16.35 h to 11.85 h, as the 
concentration of gum in the internal aqueous phase increased that 
represented the microsphere had the capability to retard the release. 
That means it can be used as a sustained drug delivery formulation. 
The higher the volume of W1 phase, increased the porosity of the 
wall of the microcapsules and resulted in faster drug release [28]. 
SEM photographs showed the presence of pores on the surface of the 
microcapsules. The development of pores may be due to leakage of 
water through the organic phase. During W1/O/W2 emulsion solvent 
evaporation method, organic liquid diffuses from W1/O droplets to 
the external aqueous phase and simultaneously water from the 
external aqueous phase back diffuses into the droplets. The back 
diffusion was related to the difference in the osmolarity between the 
internal and external phases. The greater the back diffusion, the 
greater is the leakage of water [29] and hence, the wall of the 
microcapsules became more porous providing faster drug release. 
The drug release properties of the microspheres showed a regular 
release pattern of the drugs up to twelve hours. The f2 batch having 
lowest content of guar gum showing a reasonable release of drug for 
sustained delivery. But as the guar gum concentration increases the 
release of the drug becomes lower, possibly due to the more viscous 
nature in the W1 phase with the increase in the concentration of guar 
gum in the W1 phase hindered the release of the drug [30].  
CONCLUSION 
In this research work, guar gum and sodium alginate were used as a 
matrix building material. Guar gum matrix microsphere of metformin, an 
anti-diabetic drug, was prepared by W1/O/W2 emulsion solvent 
evaporation method. Hematological, histopathological and toxicological 
data represented that guar gum is safe and nontoxic. With the increase in 
the guar gum concentration, it was found to entrap more amounts of 
drugs up to a certain extent, and the release of the drug is also dependent 
on the concentration of the guar gum in a sustained manner.  
The release of the drug from the entire microsphere appeared to be 
biphasic releasing less amount of drug in pH 1.2 and higher amount of 
drug in pH 6.8. The results of this study indicate that microcapsules 
prepared with guar gum as matrix material could be a suitable 
controlled release dosage form of metformin having high DEE that 
may release less amount of drug in stomach minimizing the 
emergence of gastric adverse effects and at the same time may provide 
a prolonged release in the intestine to achieve better drug therapy.  
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